Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort

J Infect. 2018 Jan;76(1):78-85. doi: 10.1016/j.jinf.2017.10.008. Epub 2017 Oct 23.

Abstract

Background: Non-occupational post-exposure prophylaxis (nPEP) is a recommended public health intervention after a sexual or percutaneous exposure to human immunodeficiency virus (HIV).

Methods: We conducted a prospective observational study recording consultations for nPEP at a reference HIV center in Brussels, Belgium from January 2011 to December 2015. We recorded attendance to follow-up, reported completion of nPEP and pharmacy records to measure adherence. Multivariate logistic regressions were performed to identify independent risk factors for adherence to nPEP and attendance to first follow-up visit at the STI clinic.

Findings: Among 1881 patients receiving nPEP, 66.4% had a documented completion of a 28-day course of nPEP and 87.3% attended their first follow-up clinic visit. MSM (OR, 1.40; 95%CI, 1.04-1.90), being a native Belgian (OR, 1.50; 95%CI, 1.18-1.90), older age (OR, 1.02; 95%CI, 1.01-1.04), being a sexual assault survivor (OR, 0.59; 95%CI, 0.38-0.91), having had a previous nPEP treatment (OR, 1.44; 95%CI, 1.02-2.02), consultation during daytime (OR, 1.35; 95%CI, 1.07-1.70) and benefitting from a health insurance (OR, 2.11; 95%CI, 1.58-2.89) were significant independent predictors for adherence to nPEP. Patients whose initial treatment was AZT/3TC/IDV/r had similar adherence than patients on d4T/3TC/LPV/r (OR, 0.898; 95%CI, 0.68-1.20).

Interpretation: Multiple independent risk factors for nPEP retention into care and adherence are present at treatment initiation and might be targeted by tailored interventions. Sexual assault victims are overexposed to deleterious consequences of the lack of health insurance on compliance.

Keywords: HIV; HIV prevention; Medication adherence; Post-exposure prophylaxis; Sexual assault survivors.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Belgium
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • HIV Infections / etiology
  • HIV Infections / prevention & control*
  • Humans
  • Insurance, Health
  • Male
  • Patient Compliance*
  • Post-Exposure Prophylaxis*
  • Prospective Studies
  • Regression Analysis
  • Risk Factors
  • Sex Offenses

Substances

  • Anti-HIV Agents